Practicing traditional Chinese medicine in the COVID-19 pandemic in Switzerland – an exploratory study

Author:

Bourqui AngéliqueORCID,Rodondi Pierre-YvesORCID,El May EmnaORCID,Dubois JulieORCID

Abstract

Abstract Background To curb the spread of the first wave of the COVID-19 pandemic, the Swiss government declared a state of health emergency and ordered a legal restriction concerning the opening of healthcare institutions. In this study, we aimed to assess the proportion of traditional Chinese medicine (TCM) physicians and therapists who consulted patients regarding COVID-19 during the first wave of the pandemic in 2020 in Switzerland, as well as the extent to which COVID-19 affected their practices during the same period. Methods A retrospective study was performed by using a questionnaire from January to April 2021 among a random sample of TCM physicians and therapists based in Switzerland. The survey included questions on demographic characteristics, opening status of practices, channels of communication used for the medical encounter, and experience in managing the prevention, acute, and recovery stages of COVID-19 infection. Results Among the 320 participants, 76% consulted a patient regarding COVID-19 at least once. Overall, physicians and therapists consulted more patients during recovery (76.3%) and prevention (67.8%) than during the acute stage (19.8%) of the disease. Acupuncture was the most frequently used technique among TCM therapists and physicians consulting for prevention (80.4%) and recovery (92.5%), whereas Chinese pharmacopeia was the most used technique among those consulting for the acute stage (59.3%). Of those who closed their practices from March to April 2020 but kept consulting, telephone (30.4%) and home visits (29.9%) were the two principal methods of consultation. Conclusions The restriction concerning the opening of practices induced a loss of the health workforce, especially among TCM therapists. Nonetheless, TCM therapists and physicians consulted patients regarding COVID-19, especially during the recovery stage. As there is a demand for the use of TCM in the context of COVID-19, it raises the need for a better consideration of TCM in the Swiss health care system.

Publisher

Springer Science and Business Media LLC

Subject

Complementary and alternative medicine

Reference35 articles.

1. Geneva Centre for Security Policy (GCSP). Coronavirus/COVID-19 - Key Information for our community and guests. 2020. https://www.gcsp.ch/covid-19. Accessed 13 July 2020.

2. FOPH. COVID-⁠19 Switzerland : Overview of the epidemiological situation. 2020. https://www.bag.admin.ch/bag/fr/home/krankheiten/ausbrueche-epidemien-pandemien/aktuelle-ausbrueche-epidemien/novel-cov/situation-schweiz-und-international.html#-1315239417. Accessed 19 April 2022.

3. Fedlex. Ordinance 3 of 19 June 2020 on Measures to Combat the Coronavirus. 2020. https://www.fedlex.admin.ch/eli/cc/2020/141/en. Accessed 19 April 2022.

4. FOPH. Rapport explicatif concernant l’ordonnance 2 du 13 mars 2020 sur les mesures destinées à lutter contre le coronavirus (ordonnance 2 COVID-19), version du 25 mars 2020. 2020.

5. Collectif de Praticiens Prescripteurs en pharmacopée (phytothérapie) de la Médecine Chinoise. COVID-19 Collectif Médecine Chinoise - Suisse. 2020. https://www.covid19-medecine-chinoise.ch/. Accessed 03 September 2020.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3